Mesenchymal Stem Cells (MSCs) and Breast Cancer

Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be found throughout the body. MSCs have the ability to self-renew and differentiate into a variety of cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells), adipocytes (fat cells), and more. In recent years, MSCs have been shown to have therapeutic potential in a variety of diseases, including cancer. In breast cancer, MSCs are thought to play a role in tumor progression and metastasis. MSCs can promote the growth of cancer cells and help them to spread to other parts of the body. MSCs may also help to protect cancer cells from the immune system. There is a growing body of evidence to suggest that MSCs could be a potential target for cancer therapy. In preclinical studies, MSCs have been shown to be effective at killing cancer cells and slowing the growth of tumors. MSCs may also have the ability to improve the efficacy of other cancer treatments, such as chemotherapy and radiation therapy. Clinical trials are currently underway to assess the safety and efficacy of MSC-based cancer therapy in humans. If proven to be safe and effective, MSCs could potentially revolutionize the way we treat cancer.

 "Mesenchymal stem cells confer chemoresistance in breast cancer ...." 28 May. 2019, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544397/. Accessed 25 Oct. 2022.

 "Mesenchymal stem cells in breast cancer: response to chemical and ...." 28 Nov. 2017, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769973/. Accessed 25 Oct. 2022.

 "Mesenchymal stem cells and cancer therapy: insights into targeting ...." 8 Mar. 2021, https://cancerci.biomedcentral.com/articles/10.1186/s12935-021-01836-9. Accessed 25 Oct. 2022.

The information below is the recommended stem cell therapy protocol for this condition 

Route of AdministrationDoseTime (Days)Total Cells
IV100,000,0002200,000,000
Myers cocktail/NAD1N/A
Total200,000,000